Chris Simms
Chief Commercial Officer
Chris Simms joined 4DMT in 2024 as Chief Commercial Officer. He is an accomplished healthcare leader with more than 20 years of diverse commercial leadership experience at Iveric Bio, Johnson & Johnson, Genentech and Novartis, including focused experience in retina, ophthalmology and optometry. Most recently, Mr. Simms was SVP and Chief Commercial Officer at Iveric, where he built and led the commercial team from pre-commercialization through the successful U.S. launch of IZERVAY.
Prior to joining Iveric, Mr. Simms served as Vice President and Head of the Novartis U.S. Ophthalmics business unit, which included the brands BEOVU® and Xiidra®. He joined Novartis in 2017 to build the commercial launch strategy for BEOVU® after leading commercial efforts on LUCENTIS® at Genentech. Before Genentech, he spent 16 years at Johnson & Johnson working with leading brands across their vision care, diabetes and consumer goods businesses in Canada, Japan and the U.S.
Mr. Simms has a Bachelor of Commerce from Memorial University of Newfoundland and an MBA from York University, Toronto, Canada.